Melanocyte protein PMEL;gp100
CAT No: ta-023
CAS No:181477-43-0
Synonyms/Alias:Disomotide;181477-43-0;Disomotide [USAN:INN];UNII-8028PPX4PM;disomotida;MPS 22;MPS-22;8028PPX4PM;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoic acid;DTXSID50171158;Gp100:209-217(210m) peptide;Gp-100:209-217(210m) peptide;(186-L-Methionine)melanocyte protein Pmel 17 (human melanoma-associated ME20 antigen)-(185-193)-peptide;L-Valine, L-isoleucyl-L-methionyl-L-alpha-aspartyl-L-glutaminyl-L-valyl-L-prolyl-L- phenylalanyl-L-seryl-;Disomotide [USAN];disomotidum;DISOMOTIDE [INN];DISOMOTIDE [WHO-DD];CHEMBL263429;DTXCID4093649;BDBM50409410;FM109412;HY-105039;Q27269103;H-Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val-OH; H-IMDQVPFSV-OH;(Met186)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) trifluoroacetate salt;L-VALINE, L-ISOLEUCYL-L-METHIONYL-L-.ALPHA.-ASPARTYL-L-GLUTAMINYL-L-VALYL-L-PROLYL-L-PHENYLALANYL-L-SERYL-;L-VALINE, L-ISOLEUCYL-L-METHIONYL-L-ALPHA-ASPARTYL-L-GLUTAMINYL-L-VALYL-L-PROLYL-L-PHENYLALANYL-L-SERYL-;
gp100 (209-217) is a synthetic peptide corresponding to amino acid residues 209 to 217 of the human glycoprotein 100 (gp100), a melanoma-associated antigen widely studied in immunology and cancer research. As a defined epitope within the gp100 protein, this peptide is recognized by cytotoxic T lymphocytes (CTLs) and serves as a critical tool for investigating antigen processing, T cell recognition, and immune targeting of melanocytic cells. Its precise sequence and immunogenic properties have established it as a valuable reagent in the fields of tumor immunology, peptide-based assay development, and cellular immunotherapy research.
Epitope Mapping: In immunological research, gp100 (209-217) is extensively utilized for the mapping and characterization of T cell epitopes. By presenting this peptide to T cell populations, researchers can assess the specificity and functional responsiveness of cytotoxic T lymphocytes against gp100-expressing cells. Such studies are essential for elucidating the molecular determinants of antigen recognition and for identifying immunodominant regions relevant to tumor-associated antigens.
Antigen Presentation Studies: The peptide serves as a model substrate for investigating the mechanisms of antigen processing and presentation by major histocompatibility complex (MHC) class I molecules. By loading the peptide onto antigen-presenting cells, scientists can dissect the efficiency of peptide-MHC complex formation, peptide stability, and subsequent T cell activation. These applications are fundamental for understanding how immune surveillance operates at the molecular level and for optimizing antigen delivery strategies in experimental systems.
T Cell Activation Assays: gp100 (209-217) is frequently employed in functional assays to stimulate and monitor gp100-specific T cell responses. In vitro stimulation with this peptide enables quantification of cytokine production, proliferation, and cytolytic activity of antigen-specific T cells. Such assays are instrumental in evaluating the efficacy of immune interventions, screening for T cell reactivity, and validating peptide immunogenicity in preclinical research.
Peptide-Based Vaccine Research: The defined immunogenic sequence of this peptide makes it a candidate for use in the development and optimization of peptide-based vaccine platforms. Researchers leverage its ability to elicit targeted T cell responses in experimental models, facilitating the design and refinement of synthetic vaccines aimed at inducing robust cellular immunity against melanoma-associated antigens. These investigations support the broader goal of advancing antigen-specific immunotherapeutic strategies.
Assay Development and Standardization: As a well-characterized synthetic peptide, gp100 (209-217) is commonly incorporated into protocols for assay calibration, quality control, and standardization in immunological studies. Its use ensures reproducibility and comparability across experimental runs, particularly in flow cytometry, ELISPOT, and tetramer-based assays that quantify antigen-specific T cell populations. By providing a consistent and defined antigenic stimulus, it supports rigorous experimental design and data interpretation in both basic and translational research settings.
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More